I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Intraocular Tumors: Understanding Diagnosis, Types, and Treatment
What Is an Intraocular Tumor?
Intraocular tumors are growths that develop within the structures inside the eye. They can be benign (non-cancerous) or malignant (cancerous), and they differ considerably in how they grow, where they form, and how they affect vision.
The eye contains several distinct layers and structures, and tumors can arise from different cell types within them. The uvea is the middle layer of the eye wall and includes the iris (the colored ring around the pupil), the ciliary body (which controls lens focusing), and the choroid (a layer rich in blood vessels behind the retina). The retina is the light-sensitive tissue at the back of the eye that converts light into visual signals sent to the brain.
Tumors that begin in the uvea are called uveal tumors. Those that form in the retina are retinal tumors. Some tumors reach the eye by spreading from a cancer located elsewhere in the body, and these are known as metastatic tumors.
The way a tumor develops depends on the type of cell involved. Uveal melanoma, the most common primary eye cancer in adults, arises from melanocytes, which are the pigment-producing cells found throughout the uveal tract. Researchers have identified specific genetic changes, including mutations in the GNAQ and GNA11 genes, that contribute to the formation and growth of these tumors.
Retinoblastoma, the most common intraocular cancer in children, develops when both copies of the RB1 gene become inactive. This gene normally helps prevent cells from growing out of control, and when it fails to function, tumor cells multiply within the retina. Intraocular lymphoma involves the uncontrolled growth of lymphocytes, a type of white blood cell, within the eye.
Types of Intraocular Tumors
Several distinct types of intraocular tumors exist, each with different characteristics, risk profiles, and treatment approaches. Knowing the specific tumor type is the foundation of any care plan.
Uveal melanoma is the most common primary eye cancer in adults. The term 'primary' means it originates in the eye itself rather than spreading from another site in the body. Most uveal melanomas develop in the choroid, though they can also arise from the iris or ciliary body. Without treatment, these tumors can damage vision and carry a risk of spreading to other organs, most commonly the liver.
Retinoblastoma is the most common intraocular cancer in children. It develops in the retina and is closely linked to changes in the RB1 gene. In some children, this gene change is present throughout every cell of the body, a condition called heritable retinoblastoma. Children with this form may develop tumors in both eyes and face a higher lifetime risk of other cancers.
Intraocular lymphoma is a rare but serious cancer involving lymphocytes, a type of immune cell. It frequently occurs alongside primary central nervous system (CNS) lymphoma, which is cancer affecting the brain and spinal cord. Because of this connection, evaluation and treatment often require coordination between a retina specialist and a neurologist or neuro-oncologist.
Metastatic intraocular tumors occur when cancer from another part of the body spreads to the eye. These are actually the most common type of intraocular tumor overall. Breast cancer and lung cancer are among the most frequent sources of eye metastases. Anyone with a known cancer history should be aware that new visual changes could signal spread to the eye and should report them to both their oncologist and eye care provider.
Not all intraocular growths are cancerous. Choroidal nevi, sometimes called eye freckles, are flat pigmented spots on the choroid that are usually harmless but require regular monitoring because a small number can transform into melanoma over time. Choroidal hemangiomas are benign vascular growths that may affect vision depending on their size and location. Careful observation is the cornerstone of managing most benign intraocular growths.
Who Is at Risk?
Different types of intraocular tumors affect different populations. Understanding the risk factors helps guide screening decisions and ensures that high-risk individuals receive timely evaluation.
Uveal melanoma most commonly affects adults, typically in their 60s. In the United States, choroidal melanoma affects approximately 2,500 people each year, according to the American Society of Retina Specialists. Several characteristics are associated with a higher likelihood of developing this condition.
- Fair skin and light-colored eyes
- Difficulty tanning or a history of significant sun exposure
- Ocular or oculodermal melanocytosis (excess pigmentation in or around the eye)
- History of choroidal, iris, or skin nevi
- A mutation in the BAP1 gene (BRCA1-associated protein 1)
- Smoking history
Adults with these risk factors should discuss appropriate screening schedules with their eye care provider, since many uveal melanomas are detected during routine dilated eye exams before any symptoms develop.
Retinoblastoma primarily affects young children, most often under age five. It accounts for roughly 10 percent of all cancers in the first year of life. The primary risk factor is a change in the RB1 gene, which can be inherited from a parent or can arise spontaneously in the developing retina.
Children with heritable retinoblastoma carry this gene change in every cell of their body, making them more likely to develop tumors in both eyes and at increased risk for other cancers throughout their lives. Genetic counseling is strongly recommended for families affected by retinoblastoma.
Metastatic intraocular tumors occur in people who already have cancer elsewhere in the body. Breast cancer and lung cancer are the most common sources. Any person with a known cancer diagnosis should report new visual symptoms to both their oncologist and their eye care provider without delay.
Intraocular lymphoma tends to affect older adults and people with compromised immune systems. It is closely associated with CNS lymphoma, and its diagnosis often requires both an ocular and a systemic evaluation involving multiple specialists.
Signs and Symptoms
Intraocular tumors do not always cause noticeable symptoms in their early stages. When symptoms do appear, they can vary depending on the tumor type, size, and its location within the eye.
Many intraocular tumors are discovered during routine eye examinations before a patient notices any changes. When symptoms do develop, the most common include floaters (spots, shadows, or web-like shapes drifting through your vision), flashes of light, and a gradual decline in vision in the affected eye.
Vision loss can occur through several different mechanisms. The tumor may press on or grow into the part of the retina responsible for central vision. It can also cause fluid to accumulate under the retina (called subretinal fluid), lead to cataract formation, trigger a retinal detachment, or cause vitreous hemorrhage, which is bleeding into the clear gel that fills the interior of the eye.
A scotoma is a blind spot or a patch of reduced vision within your visual field. It can develop when a tumor involves the retina near the fovea, which is the small central area responsible for sharp, detailed sight. Some patients notice a persistent shadow or a missing segment in their peripheral (side) vision. These changes may develop gradually and can be easy to overlook in the early stages.
The most recognizable sign of retinoblastoma in children is leukocoria, a white pupil reflex. Rather than the normal dark or reddish appearance, the pupil may appear to have a white or yellowish glow, especially in photographs taken with a flash. This is not a normal finding and always requires prompt evaluation by a specialist.
Other warning signs in children include eyes that appear to look in different directions (strabismus), redness, swelling, or a change in iris color. Any parent who notices these findings should seek an evaluation right away, as early detection is critical for preserving vision and protecting overall health.
How Intraocular Tumors Are Diagnosed
Accurate diagnosis is the essential first step in managing any intraocular tumor. Our team uses a combination of clinical examination and advanced imaging technology to evaluate each case thoroughly before recommending a course of action.
Diagnosis typically begins with a comprehensive dilated eye examination. Dilating the pupil with eye drops allows the retina specialist to see the full interior of the eye, including the retina, choroid, and vitreous. Using specialized instruments, the specialist can assess the presence, size, location, and physical characteristics of a tumor. This examination alone often provides enough initial information, particularly for choroidal nevi and early choroidal melanoma.
Several imaging technologies help our specialists examine intraocular tumors with greater precision and detail. These tools allow us to document the tumor accurately, track any changes over time, and plan treatment with confidence.
- Optical coherence tomography (OCT): Produces high-resolution cross-sectional images of the retina, revealing fluid accumulation or subtle structural changes caused by the tumor.
- OCT angiography: Maps the blood vessels in and around the tumor without requiring an injection of dye.
- Wide-field imaging and fundus photography: Captures detailed photographs of the interior of the eye to document the tumor's appearance and monitor it over follow-up visits.
- B-scan ultrasound: Uses sound waves to measure tumor thickness and evaluate its internal structure, helping to distinguish different tumor types.
- Fluorescein angiography: Involves injecting a dye into a vein to highlight blood vessel patterns in and around the tumor, providing information about its vascularity.
- Indocyanine green (ICG) angiography: Offers complementary information about the deeper blood vessels of the choroid beneath the tumor.
Advances in intraocular biopsy techniques now allow specialists to obtain small tissue samples from eye tumors for laboratory analysis. For uveal melanoma in particular, molecular genetic testing of biopsy material has become an important tool for both diagnosis and determining a patient's prognosis, meaning their likelihood of the cancer spreading.
Prognostic testing can identify chromosomal changes that predict whether a uveal melanoma has a high potential to spread to other organs. This information helps guide treatment planning and the frequency of systemic follow-up care after the eye has been treated.
Treatment Options
Treatment for intraocular tumors depends on the type, size, and location of the tumor, as well as each patient's overall health and vision goals. Our team evaluates each case individually and discusses all appropriate options in detail before any decisions are made.
Radiation therapy is the most widely used treatment for uveal melanoma. Plaque brachytherapy involves placing a small radioactive disc, called a plaque, on the outer wall of the eye directly over the tumor. The plaque delivers a targeted dose of radiation to the tumor over several days and is then surgically removed. This approach concentrates treatment at the tumor while minimizing exposure to surrounding healthy tissue.
External beam radiation options include proton beam therapy, helium ion radiation, and stereotactic radiosurgery, all of which deliver high-energy radiation from outside the body with precision. The goal of radiation therapy is to destroy the tumor while preserving as much of the eye and vision as possible.
Laser-based treatments are typically offered for smaller tumors. These procedures use focused beams of light energy to destroy tumor cells. Photodynamic therapy (PDT) uses a light-activated medication injected into the bloodstream that is then activated by a specific wavelength of light directed at the tumor. PDT may be used as a primary treatment or combined with other therapies depending on tumor size, location, and other individual factors.
Surgical options include vitrectomy (removal of the gel-like vitreous humor inside the eye) and direct tumor resection, which is the surgical removal of the tumor tissue itself. In cases where the tumor is very large, has caused extensive damage, or cannot be safely managed with other treatments, enucleation (surgical removal of the entire eye) may be recommended.
Enucleation is generally considered only when other treatments cannot adequately control the disease. After enucleation, a natural-looking prosthetic eye can be fitted to restore cosmetic appearance.
Retinoblastoma treatment has advanced considerably in recent years, with local treatment approaches now playing a central role. These include plaque brachytherapy, intra-arterial chemotherapy (delivering medication directly to the eye through a small catheter placed in a blood vessel), and intravitreal chemotherapy (injecting medication directly into the vitreous cavity of the eye). These targeted methods aim to destroy the tumor while reducing systemic side effects.
The choice of treatment depends on the tumor's size and position, whether one or both eyes are affected, and whether the cancer has spread beyond the eye to surrounding structures or elsewhere in the body.
Intraocular lymphoma may be treated with intravitreal injections of methotrexate, a chemotherapy medication delivered directly into the eye. Because this condition is frequently linked to CNS lymphoma, treatment often also involves systemic chemotherapy or radiation therapy coordinated between a retina specialist and an oncology team. Regular monitoring of both the eye and the central nervous system is an ongoing part of care.
What to Expect During and After Treatment
Navigating an intraocular tumor diagnosis involves both the clinical process and the very real emotional challenge of facing a serious eye condition. We work closely with each patient to provide clear expectations at every stage of care.
After a tumor is detected, you can expect a thorough evaluation that may include multiple imaging studies and possibly a biopsy. Your retina specialist will explain the tumor type, size, and location, as well as the significance of any diagnostic findings. For uveal melanoma, molecular genetic testing may be recommended to assess the likelihood of spread to other organs.
Treatment planning is always individualized. Your specialist will walk you through the available options, the expected benefits of each, the potential risks involved, and the likely effect on your vision. We encourage you to ask questions and take the time you need to feel confident in your care plan.
Follow-up care after treatment is an essential part of managing intraocular tumors. Monitoring typically includes regular dilated eye exams, repeat imaging studies, and for uveal melanoma specifically, systemic evaluations to screen for cancer spread. The liver is the most common site of uveal melanoma metastasis, and periodic liver imaging is often included in surveillance plans.
The frequency of follow-up appointments depends on the type of tumor, the treatment received, and individual risk factors identified through testing. Many patients require close surveillance for several years following initial treatment.
Vision outcomes after treatment vary widely. Some patients retain excellent vision following successful treatment, while others may experience partial or significant vision loss depending on the tumor's size, location, and involvement of critical retinal structures. Your specialist will provide a realistic picture of what to expect based on your individual situation. Low-vision rehabilitation services are available for patients whose vision is significantly affected, helping them maintain independence and quality of life.
Receiving a diagnosis of an intraocular tumor can feel overwhelming. It is completely normal to feel anxious, frightened, or uncertain about what lies ahead. Many patients find it helpful to connect with support groups, counseling services, or patient advocacy organizations focused on ocular cancers. Our team is glad to help connect you with resources that can ease the emotional burden of your diagnosis and treatment.
When to Seek Urgent or Specialist Care
Knowing when to act quickly can make a meaningful difference in outcomes. Some situations require immediate evaluation, while others call for a scheduled referral to a retina specialist.
Seek care right away if you experience a sudden increase in floaters, new or intensifying flashes of light, a curtain or shadow spreading across your vision, or sudden vision loss in one eye. These symptoms can indicate serious complications such as retinal detachment or vitreous hemorrhage, both of which require urgent evaluation and treatment to protect your sight.
If a suspicious growth or pigmented lesion is found during a routine eye exam performed by an optometrist or general ophthalmologist, a referral to a retina specialist is the appropriate next step. Adults with known risk factors for uveal melanoma should discuss appropriate screening frequency with their eye care provider.
Parents who notice a white or yellowish glow in a child's pupil, crossed eyes, or any unusual change in eye appearance should not wait. Early detection of retinoblastoma is critical for preserving vision and protecting the child's long-term health, and a timely referral can make an enormous difference in outcomes.
Frequently Asked Questions
The following questions address common concerns from patients and families who are navigating an intraocular tumor diagnosis or evaluation.
Yes, and this is one of the most compelling reasons to maintain a regular schedule of comprehensive dilated eye exams. Many choroidal melanomas and choroidal nevi are identified in patients who have no visual complaints at the time of examination. Adults over 50 and those with specific risk factors for uveal melanoma, such as light eye color or a known choroidal nevus, should prioritize consistent eye care. Earlier discovery generally allows for a broader range of treatment options and may improve long-term outcomes.
Enucleation, the surgical removal of the eye, is not the standard first treatment for most intraocular tumors. It is generally reserved for large tumors or situations where other treatments cannot safely or effectively control the disease. Many patients with uveal melanoma are treated successfully with plaque brachytherapy or external beam radiation, which preserve the eye. The goal of our team is always to balance effective tumor control with the best possible vision outcome for your individual case, and your specialist will explain all alternatives clearly before any decision is made.
No. Retinoblastoma can be either hereditary or non-hereditary. In the hereditary form, the RB1 gene mutation is present in every cell of the body and can be passed from a parent to a child. In the non-hereditary form, the mutation occurs only within the cells of the retina and is not inherited. Genetic testing can determine which form is present, which has important implications for siblings, parents, and any future children of affected individuals. Referral to a genetics specialist is typically part of care for families dealing with a retinoblastoma diagnosis.
Follow-up frequency depends on the size of the tumor at diagnosis, the results of molecular genetic testing, and the type of treatment received. In general, patients are monitored with eye exams and imaging every three to six months during the first several years following treatment. Because uveal melanoma has a known tendency to spread to the liver and other organs, systemic surveillance, which may include liver imaging, is typically recommended at regular intervals over many years. Your specialist will design a personalized surveillance plan based on your individual risk profile and genetic test results.
A white or yellowish glow in a child's pupil, known as leukocoria, should be evaluated by an eye specialist as soon as possible. While leukocoria can be caused by several different conditions, it is one of the most recognizable early warning signs of retinoblastoma. Time is critical in retinoblastoma care, as earlier treatment dramatically improves the chances of preserving vision and preventing the cancer from spreading beyond the eye. Contact your child's pediatrician or an eye specialist without delay if you notice this finding, including in photographs.
A choroidal nevus is a flat, pigmented spot on the choroid that is usually benign, much like a freckle on the skin. The vast majority remain stable and never cause problems. However, a small number can grow over time and potentially transform into a choroidal melanoma, which is why regular monitoring is important. Characteristics such as increasing size or thickness, the presence of subretinal fluid, orange pigment on the surface, or proximity to the optic nerve help determine how closely a nevus needs to be watched. Your retina specialist will use imaging studies to track any changes at each visit.
Visit New England Retina Associates
At New England Retina Associates, our fellowship-trained vitreoretinal surgeons are experienced in evaluating and managing the full range of intraocular tumors, from routine nevus monitoring to complex cases requiring coordinated specialty care. We serve patients throughout Connecticut with four conveniently located offices and a commitment to providing expert retina care in a setting that is both thorough and supportive. If you have been referred for evaluation or are concerned about a finding in your eye, we welcome you to schedule a consultation with our team.
30 Years of Care & Commitment
